FDA Inspection
WuXi Advanced TherapiesWuXi Advanced Therapies – FDA Inspection, Nov 25, 2025
Record Details
This FDA Inspection record concerns WuXi Advanced Therapies, with an inspection on November 25, 2025, issued by the Philadelphia District Office, covering biologics.
View Company Profile
ID · 3ea12386-b657-449c-b644-e365d8fe3cee
Inspection Facts
- Inspection number
- 1299454
- FDA center
- Biologics
Other FDA inspections of WuXi Advanced Therapies
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 1, 2023 | Not classified | Philadelphia District Office | |
| January 22, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 17, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for WuXi Advanced Therapies
- FDA Inspection 1262215 - 2025-02-07
- FDA Inspection 1230154 - 2023-09-01
- FDA Inspection 1121335 - 2020-01-22
- FDA Inspection 921995 - 2015-04-17
- FDA Inspection 849366 - 2013-09-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.